| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 73.2 | ¤796,273 | US |
| JNJ | Johnson & Johnson | 57.1 | ¤379,479 | US |
| ABT | Abbott Laboratories | 63.3 | ¤227,161 | US |
| MRK | Merck & Co., Inc. | 72.5 | ¤196,278 | US |
| ISRG | Intuitive Surgical, Inc. | 62.1 | ¤172,954 | US |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 67.0 | ¤11,346 | US |
| THC | Tenet Healthcare Corporation | 57.7 | ¤11,495 | US |
| ALGN | Align Technology, Inc. | 51.0 | ¤12,549 | US |
| UTHR | United Therapeutics Corporation | 76.6 | ¤12,788 | US |
| HOLX | Hologic, Inc. | 55.8 | ¤12,916 | US |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| AMGN | Amgen Inc. | 54.2 | 30 | US |
| LLY | Eli Lilly and Company | 73.2 | 25 | US |
| PFE | Pfizer Inc. | 63.3 | 23 | US |
| DGX | Quest Diagnostics Incorporated | 53.2 | 21 | US |
| ZTS | Zoetis, Inc. Class A | 58.2 | 21 | US |
| JNJ | Johnson & Johnson | 57.1 | 20 | US |
| TMO | Thermo Fisher Scientific Inc. | 51.8 | 20 | US |
| RMD | ResMed Inc. | 69.1 | 18 | US |
| UTHR | United Therapeutics Corporation | 76.6 | 17 | US |
| A | Agilent Technologies, Inc. | 49.6 | 15 | US |
| Average Market Cap | ¤96,730 |
| Median Market Cap | ¤29,217 |
| Avg. 3 Mo. Dollar Vol. | ¤588,633,575 |
| Avg. 3 Mo. Trading Vol. | 4,667,749 |
| Last Rebalance Date | 03/24/2025 |
| Companies Replaced | 20 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 25.9 |
| Forward P/E Ratio (12 Mo.) | 18.4 |
| Price/Book Ratio | 4.0 |
| Avg. Revenue Chg. - 3 Yr | 19.0% |
| Avg. Op. Income Chg. - 3 Yr. | 19.2% |
| Avg. EPS Growth - 3 Yr. | 7.5% |
| Avg. EPS Growth - 1 Yr. | 10.7% |
| Avg. Operating Margin | 22.5% |
| Avg. LT Debt to Total Capital | 34.7% |
| Avg. Return on Equity | 19.2% |
| Dividend Yield | 0% |
| US Health Care Index | 57.12 |
| United States Of America | 93.33% |
| Switzerland | 3.33% |
| Ireland | 3.33% |
